The multidimensional nature of dyspnoea in amyotrophic lateral sclerosis patients with chronic respiratory failure: Air hunger, anxiety and fear

被引:34
作者
Morelot-Panzini, Capucine [1 ,2 ]
Perez, Thierry [3 ,4 ]
Sedkaoui, Kamila [5 ]
de Bock, Elodie [6 ]
Aguilaniu, Bernard [7 ]
Devillier, Philippe [8 ]
Pignier, Christophe [9 ]
Arnould, Benoit [6 ]
Bruneteau, Gaelle [10 ,11 ]
Similowski, Thomas [1 ,2 ]
机构
[1] Sorbonne Univ, INSERM, Neurophysiol Resp Expt & Clin UMRS1158, F-75005 Paris, France
[2] Grp Hosp Pitie Salpetriere Charles Foix, AP HP, Serv Pneumol & Reanimat Med, Dept R3S, F-75013 Paris, France
[3] CHU Lille, Clin Malad Resp, F-59000 Lille, France
[4] Inst Pasteur, Ctr Infect & Immun Lille, INSERM, U1019,CNRS,UMR 8204, F-59000 Lille, France
[5] Ctr Hosp Reg & Univ Toulouse, Hop Larrey, Serv Pneumol, Toulouse, France
[6] Mapi, Patient Ctr Outcomes, Lyon, France
[7] Univ Grenoble Alpes, Grenoble, France
[8] Hop Foch, UPRES EA220, Suresnes, France
[9] Pierre Fabre Medicament, Castres, France
[10] Sorbonne Univ, Inst Cerveau & Moelle Epiniere, INSERM, U1127,ICM,CNRS,UMR 7225, F-75013 Paris, France
[11] Hop La Pitie Salpetriere, AP HP, Dept Neurol, Ctr Referent SLA, F-75013 Paris, France
关键词
Dyspnoea; Amyotrophic lateral sclerosis; Chronic respiratory failure; Noninvasive ventilation; Multidimensional dyspnea profile; Patient-reported outcomes; PALLIATIVE CARE; MANAGEMENT; BREATHLESSNESS; RELIABILITY; DEPRESSION; SCALES; LIFE;
D O I
10.1016/j.rmed.2018.10.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder leading to chronic respiratory failure. Few studies have investigated ALS-related dyspnoea, and none have characterised the emotional distress it inflicts. We hypothesised that ALS-related dyspnoea has a strong affective component that relates to quality of life. Methods: This prospective, observational study was conducted in 41 ALS patients > 18 with chronic respiratory failure and an indication for noninvasive ventilation (NIV). Dyspnoea was assessed using the Multidimensional Dyspnea Profile (MDP) at baseline and 1 month after NIV initiation. Correlations between scores evaluating the sensory and affective dimensions of dyspnoea and other patient-reported outcomes and pulmonary function tests were analysed. Results: Dyspnoea was described as intense (median [IQR] score on a 0-10 scale: 6.5 [4.0-7.5]). The sensory dimension of dyspnoea was polymorphic, but "air hunger" was the most common (48.8%) and the most intense (6 [4-8]) sensory descriptor. In the affective domain, most patients rated "anxious" (85.4%) and "afraid" (60.9%) above 0. The MDP affective dimension correlated significantly with other patient-reported outcomes, with the strongest correlation being between MDP "anxious" and the anxiety component of the Hospital Anxiety Depression Scale (Pearson's R = 0.70). One month after initiation of NIV, dyspnoea during unassisted breathing was described in virtually the same terms, particularly the affective dimension. Discussion: ALS-related dyspnoea is intense and fear-provoking, persists during unassisted breathing between NIV sessions, and significantly impacts health-related quality of life. This study highlights the need for increased awareness of and research into ALS-related dyspnoea.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 38 条
[1]   Multidimensional Dyspnea Profile: an instrument for clinical and laboratory research [J].
Banzett, Robert B. ;
O'Donnell, Carl R. ;
Guilfoyle, Tegan E. ;
Parshall, Mark B. ;
Schwartzstein, Richard M. ;
Meek, Paula M. ;
Gracely, Richard H. ;
Lansing, Robert W. .
EUROPEAN RESPIRATORY JOURNAL, 2015, 45 (06) :1681-1691
[2]   Effective management of breathlessness: a review of potential human rights issues [J].
Basoglu, Metin .
EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (05)
[3]   Amyotrophic lateral sclerosis and palliative care: Where we are, and the road ahead [J].
Blackhall, Leslie J. .
MUSCLE & NERVE, 2012, 45 (03) :311-318
[4]   El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis [J].
Brooks, BR ;
Miller, RG ;
Swash, M ;
Munsat, TL .
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS, 2000, 1 (05) :293-299
[5]   Invisible suffering: breathlessness in and beyond the clinic [J].
Carel, Havi ;
Macnaughton, Jane ;
Dodd, James .
LANCET RESPIRATORY MEDICINE, 2015, 3 (04) :278-279
[6]  
Carvalho Tatiana Lins, 2016, Trends Psychiatry Psychother., V38, P1, DOI 10.1590/2237-6089-2015-0030
[7]   Morphine in the management of dyspnoea in ALS. A pilot study [J].
Clemens, K. E. ;
Klaschik, E. .
EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (05) :445-450
[8]   Coordinated care affects hospitalization and prognosis in amyotrophic lateral sclerosis: a cohort study [J].
Cordesse, Valerie ;
Sidorok, Florence ;
Schimmel, Priscilla ;
Holstein, Josiane ;
Meininger, Vincent .
BMC HEALTH SERVICES RESEARCH, 2015, 15
[9]   The active identification and management of chronic refractory breathlessness is a human right [J].
Currow, David C. ;
Abernethy, Amy P. ;
Ko, Danielle N. .
THORAX, 2014, 69 (04) :393-394
[10]   Management and treatment of respiratory failure associated with amyotrophic lateral schlerosis. [J].
Danel-Brunaud, V ;
Perez, T ;
Just, N .
REVUE NEUROLOGIQUE, 2005, 161 (04) :480-485